Venus Remedies Receives Approval to Supply Cephalosporin

Venus Remedies receives approval to supply cephalosporin dry powder to UNICEF

Overview

Venus Remedies recently secured good manufacturing practices (GMP) approval from the United Nations International Children's Emergency Fund (UNICEF). Its manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder, a class of ß-lactam antibiotic for treating bacterial infections, to UNICEF.

Top Standards

The company said that its adherence to the highest standards of manufacturing excellence, as evident by its compliance with WHO Technical Report Series 986, reinforces its position as a trusted partner in global healthcare supply chains.

Words from President: Global Critical Care

According to Saransh Chaudhary, president, global critical care, Venus Remedies and CEO, Venus Medicine Research Centre, ""This recognition from UNICEF further validates our relentless pursuit of excellence in pharmaceutical manufacturing. The approval will further help us make substantial contributions to global healthcare initiatives of UNICEF and positively influence communities worldwide.

Approval Benefits

The approval from UNICEF will enable Venus Remedies to partake in opportunities for the supply of essential medications, enabling the company to address critical healthcare needs in regions facing health challenges owing to lack of access to medicines.

Words from Venus Remedies

Akshansh Chaudhary, executive director, Venus Remedies, emphasised the significance of this approval, stating that the endorsement from UNICEF is aligned with our mission to enhance access to quality healthcare globally.

About UNICEF

• UNICEF, an esteemed agency of the United Nations, is recognised globally for its efforts in providing humanitarian aid and developmental support to children in need. 
• Its rigorous GMP approval process sets a benchmark for quality and safety in pharmaceutical production, and Venus Remedies' accreditation demonstrates its uncompromising adherence to these stringent standards. 
• With a presence in over 190 countries, it works to protect the well-being of children regardless of their background or circumstances.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!